newsfilter
← Latest News
GlobeNewswire·

Regeneron and Telix Announce Strategic Radiopharma Collaboration

Regeneron and Telix to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model Collaboration combines Regeneron's leading antibody discovery/development